Poster Spotlight: Meta-Analysis on NeuroAiD’s Long-Term Recovery Benefits – APSC 2025

𝗣𝗼𝘀𝘁𝗲𝗿 𝗣𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁 – 𝗔𝗣𝗦𝗖 𝟮𝟬𝟮𝟱 We are pleased to share the second of two featured posters presented by the Asian Stroke Advisory Panel (ASAP) at the Asia Pacific Stroke Conference (APSC) 2025. 📌 Poster Title: “Meta-analysis of Effect of MLC601/MLC901 on Long-Term Functional Recovery after Stroke” 👤 Presenter: Dr. Tsong-Hai Lee 📅 Date & Time: 14 September 2025 | 10:05–10:45 (GMT+9) 🧠 Session: Post-Stroke and Health Service This presentation provides a comprehensive meta-analysis of functional recovery outcomes from multiple clinical trials investigating NeuroAiD (MLC601/MLC901) in stroke patients—highlighting their long-term effects on recovery. We welcome clinicians, researchers, and stroke care professionals to attend the session in Kobe, Japan, and take part in advancing conversations around long-term stroke recovery. More on APSC 2025: https://apsc2025.umin.jp/ More on ASAP: https://www.asianstrokeadvisory.com/ More on NeuroAiD: www.neuroaid.com

The release as fetched from its publisher. moleac.com ↗